Skip to main content
. 2020 Feb 20;7(10):1903164. doi: 10.1002/advs.201903164

Figure 1.

Figure 1

Steps in the production of CAR‐T cells. This usually starts with drawing blood from the patient, followed by T cell isolation. The T cells are then cultivated for some time, genetically engineered to produce specific tumor cell‐surface receptors or antigens containing the CAR sequence. After processing, the genetically modified T cells are selectively multiplied and infused back into the patient.